Inferior Vena Cava Filters in Recurrent Thromboembolism: Yes or No?

Courtesy of Dr. Guillermo Migliaro.

vena cava filters, pulmonary embolism, deep vein thrombosisAt present, there is no clear evidence in favor of inferior vena cava filters (IVC) for patients developing recurrent symptomatic venous thromboembolism (VTE), and the existing guideline recommendations from the different societies are contradicting.

 

The aim of this study was to assess the effectiveness of these devices in patients with recurrent VTE on anticoagulant therapy. The study incorporated patients with IVC filters for recurrent venous thromboembolism in the first three months of anticoagulant therapy from the RIETE registry (Registro Informatizado de la Enfermedad Tromboembólica) and locked at mortality outcomes 30 days after diagnosis, as follows:

  • all cause
  • pulmonary embolism related
  • second recurrent venous thromboembolism episode
  • major bleeding

 

Among 17 patients treated with filters and 49 matched patients treated without filters for VTE recurrence that presented as deep vein thrombosis, propensity score matching showed no significant differences in mortality (17.7% vs. 12.2%; p = 0.56).

 

When recurrent thromboembolism presented as pulmonary embolism (48 with VCF and 91 matched patients treated without VCF) there was a significant reduction in all-cause mortality: 2.1% vs. 25.3%; p = 0.02).

 

Pulmonary embolism related mortality was not significantly lower in the VCF group (2.1% vs. 17.6%; p = 0.08).

 

The authors concluded that, during the first three months of anticoagulation therapy, VCF placement in patients with recurrent VTE was associated to a benefit in survival rate in patients presenting pulmonary embolism..

 

Editorial Comment

Surprisingly, there is little evidence on inferior vena cava filters in patients with recurrent thromboembolism. The study sheds some light on a scarcely studied matter. The number of patients is small and the cause behind recurrent thromboembolism has not yet been determined and, although VCFs seem to be somewhat beneficial for patients with pulmonary embolism, the evidence is not enough for us to advocate for filters.

 

Courtesy of Dr. Guillermo Migliaro. German Hospital, Buenos Aires, Argentina.

 

Original Title: Outcomes Associated with Inferior Vena Cava Filters among Patients with Thromboembolic Recurrence During Anticoagulant Therapy.

Reference: M Mellado et al. JACC Cardiovasc Interv. 2016 Nov 3.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...